Selected research
Market Analysis & Forecast
Global Genomics & Sequencing Automation Systems Market Analysis and Forecast 2026-2032
Market perspective
The global Genomics & Sequencing Automation Systems market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Genomics & Sequencing Automation Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Genomics & Sequencing Automation Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Genomics & Sequencing Automation Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Genomics & Sequencing Automation Systems is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Genomics & Sequencing Automation Systems include Agilent Technologies, Revvity, Roche Diagnostics, QIAGEN, Hamilton Company, Tecan, Becton Dickinson, Eppendorf and MGI Tech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Genomics & Sequencing Automation Systems, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Genomics & Sequencing Automation Systems, also provides the revenue of main regions and countries. Of the upcoming market potential for Genomics & Sequencing Automation Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Genomics & Sequencing Automation Systems revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Genomics & Sequencing Automation Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Genomics & Sequencing Automation Systems revenue, projected growth trends, production technology, application and end-user industry.
Genomics & Sequencing Automation Systems Segment by Company
Agilent Technologies
Revvity
Roche Diagnostics
QIAGEN
Hamilton Company
Tecan
Becton Dickinson
Eppendorf
MGI Tech
BGI Genomics
Autobio Diagnostics
Haier Biomedical
DAAN Gene
Illumina
Thermo Fisher Scientific
Danaher
Genomics & Sequencing Automation Systems Segment by Type
Automated Liquid Handling Systems
Automated Nucleic Acid Extraction Systems
NGS Library Preparation Automation Systems
Robotic Sample Processing Workstations
Integrated Genomics Automation Platforms
Sequencing Workflow Automation Systems
Genomics & Sequencing Automation Systems Segment by Application
Pharmaceutical and Biotechnology Companies
Clinical Diagnostic Laboratories
Academic and Research Institutes
Contract Research Organizations (CROs)
Government and Public Health Laboratories
Population Genomics Centers
Genomics & Sequencing Automation Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomics & Sequencing Automation Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genomics & Sequencing Automation Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomics & Sequencing Automation Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Genomics & Sequencing Automation Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Genomics & Sequencing Automation Systems company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genomics & Sequencing Automation Systems revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Liquid Handling Systems
- Automated Nucleic Acid Extraction Systems
- NGS Library Preparation Automation Systems
- Robotic Sample Processing Workstations
- Integrated Genomics Automation Platforms
- Sequencing Workflow Automation Systems
Applications
- Pharmaceutical and Biotechnology Companies
- Clinical Diagnostic Laboratories
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Government and Public Health Laboratories
- Population Genomics Centers
Companies covered
- Agilent Technologies
- Revvity
- Roche Diagnostics
- QIAGEN
- Hamilton Company
- Tecan
- Becton Dickinson
- Eppendorf
- MGI Tech
- BGI Genomics
- Autobio Diagnostics
- Haier Biomedical
- DAAN Gene
- Illumina
- Thermo Fisher Scientific
- Danaher
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Genomics & Sequencing Automation Systems Market by Type
- 1.2.1 Global Genomics & Sequencing Automation Systems Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Automated Liquid Handling Systems
- 1.2.3 Automated Nucleic Acid Extraction Systems
- 1.2.4 NGS Library Preparation Automation Systems
- 1.2.5 Robotic Sample Processing Workstations
- 1.2.6 Integrated Genomics Automation Platforms
- 1.2.7 Sequencing Workflow Automation Systems
- 1.3 Genomics & Sequencing Automation Systems Market by Application
- 1.3.1 Global Genomics & Sequencing Automation Systems Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical and Biotechnology Companies
- 1.3.3 Clinical Diagnostic Laboratories
- 1.3.4 Academic and Research Institutes
- 1.3.5 Contract Research Organizations (CROs)
- 1.3.6 Government and Public Health Laboratories
- 1.3.7 Population Genomics Centers
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Genomics & Sequencing Automation Systems Market Dynamics
- 2.1 Genomics & Sequencing Automation Systems Industry Trends
- 2.2 Genomics & Sequencing Automation Systems Industry Drivers
- 2.3 Genomics & Sequencing Automation Systems Industry Opportunities and Challenges
- 2.4 Genomics & Sequencing Automation Systems Industry Restraints
3 Global Growth Perspective
- 3.1 Global Genomics & Sequencing Automation Systems Market Perspective (2021-2032)
- 3.2 Global Genomics & Sequencing Automation Systems Growth Trends by Region
- 3.2.1 Global Genomics & Sequencing Automation Systems Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Genomics & Sequencing Automation Systems Market Size by Region (2021-2026)
- 3.2.3 Global Genomics & Sequencing Automation Systems Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Genomics & Sequencing Automation Systems Revenue by Players
- 4.1.1 Global Genomics & Sequencing Automation Systems Revenue by Players (2021-2026)
- 4.1.2 Global Genomics & Sequencing Automation Systems Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Genomics & Sequencing Automation Systems Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Genomics & Sequencing Automation Systems Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Genomics & Sequencing Automation Systems Key Players Headquarters & Area Served
- 4.4 Global Genomics & Sequencing Automation Systems Players, Product Type & Application
- 4.5 Global Genomics & Sequencing Automation Systems Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Genomics & Sequencing Automation Systems Market CR5 and HHI
- 4.6.3 2025 Genomics & Sequencing Automation Systems Tier 1, Tier 2, and Tier 3
5 Genomics & Sequencing Automation Systems Market Size by Type
- 5.1 Global Genomics & Sequencing Automation Systems Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Genomics & Sequencing Automation Systems Revenue by Type (2021-2032)
- 5.3 Global Genomics & Sequencing Automation Systems Revenue Market Share by Type (2021-2032)
6 Genomics & Sequencing Automation Systems Market Size by Application
- 6.1 Global Genomics & Sequencing Automation Systems Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Genomics & Sequencing Automation Systems Revenue by Application (2021-2032)
- 6.3 Global Genomics & Sequencing Automation Systems Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Agilent Technologies
- 7.1.1 Agilent Technologies Company Information
- 7.1.2 Agilent Technologies Business Overview
- 7.1.3 Agilent Technologies Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.1.4 Agilent Technologies Genomics & Sequencing Automation Systems Product Portfolio
- 7.1.5 Agilent Technologies Recent Developments
- 7.2 Revvity
- 7.2.1 Revvity Company Information
- 7.2.2 Revvity Business Overview
- 7.2.3 Revvity Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.2.4 Revvity Genomics & Sequencing Automation Systems Product Portfolio
- 7.2.5 Revvity Recent Developments
- 7.3 Roche Diagnostics
- 7.3.1 Roche Diagnostics Company Information
- 7.3.2 Roche Diagnostics Business Overview
- 7.3.3 Roche Diagnostics Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.3.4 Roche Diagnostics Genomics & Sequencing Automation Systems Product Portfolio
- 7.3.5 Roche Diagnostics Recent Developments
- 7.4 QIAGEN
- 7.4.1 QIAGEN Company Information
- 7.4.2 QIAGEN Business Overview
- 7.4.3 QIAGEN Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.4.4 QIAGEN Genomics & Sequencing Automation Systems Product Portfolio
- 7.4.5 QIAGEN Recent Developments
- 7.5 Hamilton Company
- 7.5.1 Hamilton Company Company Information
- 7.5.2 Hamilton Company Business Overview
- 7.5.3 Hamilton Company Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.5.4 Hamilton Company Genomics & Sequencing Automation Systems Product Portfolio
- 7.5.5 Hamilton Company Recent Developments
- 7.6 Tecan
- 7.6.1 Tecan Company Information
- 7.6.2 Tecan Business Overview
- 7.6.3 Tecan Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.6.4 Tecan Genomics & Sequencing Automation Systems Product Portfolio
- 7.6.5 Tecan Recent Developments
- 7.7 Becton Dickinson
- 7.7.1 Becton Dickinson Company Information
- 7.7.2 Becton Dickinson Business Overview
- 7.7.3 Becton Dickinson Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.7.4 Becton Dickinson Genomics & Sequencing Automation Systems Product Portfolio
- 7.7.5 Becton Dickinson Recent Developments
- 7.8 Eppendorf
- 7.8.1 Eppendorf Company Information
- 7.8.2 Eppendorf Business Overview
- 7.8.3 Eppendorf Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.8.4 Eppendorf Genomics & Sequencing Automation Systems Product Portfolio
- 7.8.5 Eppendorf Recent Developments
- 7.9 MGI Tech
- 7.9.1 MGI Tech Company Information
- 7.9.2 MGI Tech Business Overview
- 7.9.3 MGI Tech Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.9.4 MGI Tech Genomics & Sequencing Automation Systems Product Portfolio
- 7.9.5 MGI Tech Recent Developments
- 7.10 BGI Genomics
- 7.10.1 BGI Genomics Company Information
- 7.10.2 BGI Genomics Business Overview
- 7.10.3 BGI Genomics Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.10.4 BGI Genomics Genomics & Sequencing Automation Systems Product Portfolio
- 7.10.5 BGI Genomics Recent Developments
- 7.11 Autobio Diagnostics
- 7.11.1 Autobio Diagnostics Company Information
- 7.11.2 Autobio Diagnostics Business Overview
- 7.11.3 Autobio Diagnostics Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.11.4 Autobio Diagnostics Genomics & Sequencing Automation Systems Product Portfolio
- 7.11.5 Autobio Diagnostics Recent Developments
- 7.12 Haier Biomedical
- 7.12.1 Haier Biomedical Company Information
- 7.12.2 Haier Biomedical Business Overview
- 7.12.3 Haier Biomedical Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.12.4 Haier Biomedical Genomics & Sequencing Automation Systems Product Portfolio
- 7.12.5 Haier Biomedical Recent Developments
- 7.13 DAAN Gene
- 7.13.1 DAAN Gene Company Information
- 7.13.2 DAAN Gene Business Overview
- 7.13.3 DAAN Gene Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.13.4 DAAN Gene Genomics & Sequencing Automation Systems Product Portfolio
- 7.13.5 DAAN Gene Recent Developments
- 7.14 Illumina
- 7.14.1 Illumina Company Information
- 7.14.2 Illumina Business Overview
- 7.14.3 Illumina Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.14.4 Illumina Genomics & Sequencing Automation Systems Product Portfolio
- 7.14.5 Illumina Recent Developments
- 7.15 Thermo Fisher Scientific
- 7.15.1 Thermo Fisher Scientific Company Information
- 7.15.2 Thermo Fisher Scientific Business Overview
- 7.15.3 Thermo Fisher Scientific Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.15.4 Thermo Fisher Scientific Genomics & Sequencing Automation Systems Product Portfolio
- 7.15.5 Thermo Fisher Scientific Recent Developments
- 7.16 Danaher
- 7.16.1 Danaher Company Information
- 7.16.2 Danaher Business Overview
- 7.16.3 Danaher Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
- 7.16.4 Danaher Genomics & Sequencing Automation Systems Product Portfolio
- 7.16.5 Danaher Recent Developments
8 North America
- 8.1 North America Genomics & Sequencing Automation Systems Revenue (2021-2032)
- 8.2 North America Genomics & Sequencing Automation Systems Revenue by Type (2021-2032)
- 8.2.1 North America Genomics & Sequencing Automation Systems Revenue by Type (2021-2026)
- 8.2.2 North America Genomics & Sequencing Automation Systems Revenue by Type (2027-2032)
- 8.3 North America Genomics & Sequencing Automation Systems Revenue Share by Type (2021-2032)
- 8.4 North America Genomics & Sequencing Automation Systems Revenue by Application (2021-2032)
- 8.4.1 North America Genomics & Sequencing Automation Systems Revenue by Application (2021-2026)
- 8.4.2 North America Genomics & Sequencing Automation Systems Revenue by Application (2027-2032)
- 8.5 North America Genomics & Sequencing Automation Systems Revenue Share by Application (2021-2032)
- 8.6 North America Genomics & Sequencing Automation Systems Revenue by Country
- 8.6.1 North America Genomics & Sequencing Automation Systems Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Genomics & Sequencing Automation Systems Revenue by Country (2021-2026)
- 8.6.3 North America Genomics & Sequencing Automation Systems Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Genomics & Sequencing Automation Systems Revenue (2021-2032)
- 9.2 Europe Genomics & Sequencing Automation Systems Revenue by Type (2021-2032)
- 9.2.1 Europe Genomics & Sequencing Automation Systems Revenue by Type (2021-2026)
- 9.2.2 Europe Genomics & Sequencing Automation Systems Revenue by Type (2027-2032)
- 9.3 Europe Genomics & Sequencing Automation Systems Revenue Share by Type (2021-2032)
- 9.4 Europe Genomics & Sequencing Automation Systems Revenue by Application (2021-2032)
- 9.4.1 Europe Genomics & Sequencing Automation Systems Revenue by Application (2021-2026)
- 9.4.2 Europe Genomics & Sequencing Automation Systems Revenue by Application (2027-2032)
- 9.5 Europe Genomics & Sequencing Automation Systems Revenue Share by Application (2021-2032)
- 9.6 Europe Genomics & Sequencing Automation Systems Revenue by Country
- 9.6.1 Europe Genomics & Sequencing Automation Systems Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Genomics & Sequencing Automation Systems Revenue by Country (2021-2026)
- 9.6.3 Europe Genomics & Sequencing Automation Systems Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Genomics & Sequencing Automation Systems Revenue (2021-2032)
- 10.2 China Genomics & Sequencing Automation Systems Revenue by Type (2021-2032)
- 10.2.1 China Genomics & Sequencing Automation Systems Revenue by Type (2021-2026)
- 10.2.2 China Genomics & Sequencing Automation Systems Revenue by Type (2027-2032)
- 10.3 China Genomics & Sequencing Automation Systems Revenue Share by Type (2021-2032)
- 10.4 China Genomics & Sequencing Automation Systems Revenue by Application (2021-2032)
- 10.4.1 China Genomics & Sequencing Automation Systems Revenue by Application (2021-2026)
- 10.4.2 China Genomics & Sequencing Automation Systems Revenue by Application (2027-2032)
- 10.5 China Genomics & Sequencing Automation Systems Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Genomics & Sequencing Automation Systems Revenue (2021-2032)
- 11.2 Asia Genomics & Sequencing Automation Systems Revenue by Type (2021-2032)
- 11.2.1 Asia Genomics & Sequencing Automation Systems Revenue by Type (2021-2026)
- 11.2.2 Asia Genomics & Sequencing Automation Systems Revenue by Type (2027-2032)
- 11.3 Asia Genomics & Sequencing Automation Systems Revenue Share by Type (2021-2032)
- 11.4 Asia Genomics & Sequencing Automation Systems Revenue by Application (2021-2032)
- 11.4.1 Asia Genomics & Sequencing Automation Systems Revenue by Application (2021-2026)
- 11.4.2 Asia Genomics & Sequencing Automation Systems Revenue by Application (2027-2032)
- 11.5 Asia Genomics & Sequencing Automation Systems Revenue Share by Application (2021-2032)
- 11.6 Asia Genomics & Sequencing Automation Systems Revenue by Country
- 11.6.1 Asia Genomics & Sequencing Automation Systems Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Genomics & Sequencing Automation Systems Revenue by Country (2021-2026)
- 11.6.3 Asia Genomics & Sequencing Automation Systems Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Genomics & Sequencing Automation Systems Revenue (2021-2032)
- 12.2 SAMEA Genomics & Sequencing Automation Systems Revenue by Type (2021-2032)
- 12.2.1 SAMEA Genomics & Sequencing Automation Systems Revenue by Type (2021-2026)
- 12.2.2 SAMEA Genomics & Sequencing Automation Systems Revenue by Type (2027-2032)
- 12.3 SAMEA Genomics & Sequencing Automation Systems Revenue Share by Type (2021-2032)
- 12.4 SAMEA Genomics & Sequencing Automation Systems Revenue by Application (2021-2032)
- 12.4.1 SAMEA Genomics & Sequencing Automation Systems Revenue by Application (2021-2026)
- 12.4.2 SAMEA Genomics & Sequencing Automation Systems Revenue by Application (2027-2032)
- 12.5 SAMEA Genomics & Sequencing Automation Systems Revenue Share by Application (2021-2032)
- 12.6 SAMEA Genomics & Sequencing Automation Systems Revenue by Country
- 12.6.1 SAMEA Genomics & Sequencing Automation Systems Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Genomics & Sequencing Automation Systems Revenue by Country (2021-2026)
- 12.6.3 SAMEA Genomics & Sequencing Automation Systems Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst